Showing results (741-750 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
JAMA Oncology|February 8, 2024
Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases: A Randomized, Double-Blind, Phase 3 Equivalence TrialShaohua Zhang, Yongmei Yin, Hailin Xiong, et al.
JAMA Oncology|April 4, 2024
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical TrialDavid Tougeron, Laetitia Dahan, Ludovic Evesque, et al.
JAMA Oncology|February 22, 2024
Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 PandemicTodd Burus, Feitong Lei, Bin Huang, et al.
JAMA Oncology|June 6, 2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled TrialAri J Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
JAMA Oncology|May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation TrialNoam E Kopmar, Kim Quach, Ted A Gooley, et al.
JAMA Oncology|November 9, 2023
Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-AnalysisJavier David Benitez Fuentes, Eileen Morgan, Alicia de Luna Aguilar, et al.
JAMA Oncology|November 16, 2023
Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD StudyElisabeth M Smale, Bart J F van den Bemt, Eibert R Heerdink, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Pageof 161